Suppr超能文献

2000年卢森堡白喉和百日咳的血清流行病学

Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000.

作者信息

Mossong J, Putz L, Shkedy Z, Schneider F

机构信息

Laboratoire National de Santé, Luxembourg.

出版信息

Epidemiol Infect. 2006 Jun;134(3):573-8. doi: 10.1017/S0950268805005662. Epub 2005 Nov 29.

Abstract

A large serosurvey was carried out in Luxembourg in 2000-2001, to determine the population immunity against a number of vaccine-preventable infections including diphtheria and pertussis. Immunity to diphtheria and pertussis was assessed using an in-house neutralization assay and a commercial ELISA test respectively. Mean pertussis antibody activity decreased from 4 to 8 years of age, reflecting the effects of waning of vaccine-induced immunity. Mean pertussis antibody activity increased during adolescence due to infection in previously vaccinated individuals and levelled out after approximately 20 years of age. For adults>25 years age, a statistically significant 30% difference in mean antibody activity between men and women was observed. The proportion of seronegatives for diphtheria among children and adolescents aged<20 years was 2.5% reflecting the high vaccination coverage. The proportion seronegative for diphtheria tended to increase with age such that 42% of individuals aged>40 years were seronegative. Our study supports the recently introduced acellular pertussis vaccine booster at 6 years to reduce pertussis transmission in school-aged children and adolescents.

摘要

2000年至2001年期间,卢森堡开展了一项大规模血清学调查,以确定人群对包括白喉和百日咳在内的多种疫苗可预防感染的免疫力。分别使用内部中和试验和商业酶联免疫吸附测定法评估对白喉和百日咳的免疫力。百日咳抗体平均活性在4至8岁时下降,反映出疫苗诱导免疫力减弱的影响。由于先前接种疫苗个体的感染,百日咳抗体平均活性在青春期增加,并在约20岁后趋于平稳。对于年龄>25岁的成年人,观察到男性和女性之间平均抗体活性存在统计学上显著的30%差异。20岁以下儿童和青少年中白喉血清阴性比例为2.5%,反映出高疫苗接种覆盖率。白喉血清阴性比例往往随年龄增加,40岁以上个体中有42%为血清阴性。我们的研究支持最近引入的6岁无细胞百日咳疫苗加强针,以减少学龄儿童和青少年中的百日咳传播。

相似文献

1
Seroepidemiology of diphtheria and pertussis in Luxembourg in 2000.
Epidemiol Infect. 2006 Jun;134(3):573-8. doi: 10.1017/S0950268805005662. Epub 2005 Nov 29.
2
Seroepidemiology of diphtheria and pertussis in Beijing, China: A cross-sectional study.
Hum Vaccin Immunother. 2015;11(10):2434-9. doi: 10.1080/21645515.2015.1062954.
3
Seroprevalence of antibodies to pertussis and diphtheria among healthy adults in China.
J Infect. 2011 Dec;63(6):441-6. doi: 10.1016/j.jinf.2011.07.018. Epub 2011 Aug 16.
6
Seroepidemiology of diphtheria and pertussis in Chongqing, China: serology-based evidence of Bordetella pertussis infection.
Public Health. 2018 Mar;156:60-66. doi: 10.1016/j.puhe.2017.12.009. Epub 2018 Feb 2.

引用本文的文献

1
The evaluation of anti-diphtheria toxoid antibodies in healthy population in Kon Tum, Vietnam: a population-based study.
IJID Reg. 2022 Apr 1;3:171-176. doi: 10.1016/j.ijregi.2022.03.019. eCollection 2022 Jun.
2
Whole Genome Sequencing for Surveillance of Diphtheria in Low Incidence Settings.
Front Public Health. 2019 Aug 21;7:235. doi: 10.3389/fpubh.2019.00235. eCollection 2019.
4
Seroprevalence of diphtheria toxoid IgG antibodies in children, adolescents and adults in Poland.
BMC Infect Dis. 2013 Nov 19;13:551. doi: 10.1186/1471-2334-13-551.
5
Seroepidemiology of diphtheria and tetanus among children and young adults in Tajikistan: nationwide population-based survey, 2010.
Vaccine. 2013 Oct 1;31(42):4917-22. doi: 10.1016/j.vaccine.2013.07.015. Epub 2013 Jul 13.
6
Comparison of seven commercial enzyme-linked immunosorbent assays for the detection of anti-diphtheria toxin antibodies.
Eur J Clin Microbiol Infect Dis. 2013 Jul;32(7):891-7. doi: 10.1007/s10096-013-1823-y. Epub 2013 Jan 26.
7
Use of seasonal influenza virus titer and respiratory symptom score to estimate effective human contact rates.
J Epidemiol. 2012;22(4):353-63. doi: 10.2188/jea.je20110146. Epub 2012 Apr 21.
9
Seroepidemiology of hepatitis A and hepatitis B virus in Luxembourg.
Epidemiol Infect. 2006 Aug;134(4):808-13. doi: 10.1017/S0950268805005789. Epub 2006 Jan 25.

本文引用的文献

1
A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods.
Epidemiol Infect. 2005 Apr;133(2):229-36. doi: 10.1017/s0950268804003401.
2
The seroepidemiology of Bordetella pertussis infection in Western Europe.
Epidemiol Infect. 2005 Feb;133(1):159-71. doi: 10.1017/s0950268804003012.
3
Serological surveillance of rubella in Europe: European Sero-Epidemiology Network (ESEN2).
Euro Surveill. 2004 Apr;9(4):5-7. doi: 10.2807/esm.09.04.00456-en.
5
European Sero-Epidemiology Network: standardisation of the assay results for pertussis.
Vaccine. 2003 Dec 8;22(1):112-20. doi: 10.1016/s0264-410x(03)00514-0.
7
ESEN : a comparison of vaccination programmes Part two : pertussis.
Euro Surveill. 1998 Nov;3(11):107-110. doi: 10.2807/esm.03.11.00086-en.
8
Pertussis immunisation in Europe - the situation in late 1999.
Euro Surveill. 2000 Jan;5(1):6-10. doi: 10.2807/esm.05.01.00001-en.
9
The sero-epidemiology of diphtheria in Western Europe. ESEN Project. European Sero-Epidemiology Network.
Epidemiol Infect. 2000 Aug;125(1):113-25. doi: 10.1017/s0950268899004161.
10
The changing epidemiology of diphtheria in the vaccine era.
J Infect Dis. 2000 Feb;181 Suppl 1:S2-9. doi: 10.1086/315533.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验